scholarly journals The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation

2001 ◽  
Vol 20 (5) ◽  
pp. 1086-1098 ◽  
Author(s):  
L. Wiebusch
Virology ◽  
1996 ◽  
Vol 224 (1) ◽  
pp. 150-160 ◽  
Author(s):  
Wade A. Bresnahan ◽  
Istvan Boldogh ◽  
E.Aubrey Thompson ◽  
Thomas Albrecht

2010 ◽  
Vol 6 (3) ◽  
pp. e1000814 ◽  
Author(s):  
Zhikang Qian ◽  
Van Leung-Pineda ◽  
Baoqin Xuan ◽  
Helen Piwnica-Worms ◽  
Dong Yu

1974 ◽  
Vol 13 (2) ◽  
pp. 353-362 ◽  
Author(s):  
Stephen C. St. Jeor ◽  
Thomas B. Albrecht ◽  
Fred D. Funk ◽  
Fred Rapp

2006 ◽  
Vol 80 (8) ◽  
pp. 3872-3883 ◽  
Author(s):  
Dustin T. Petrik ◽  
Kimberly P. Schmitt ◽  
Mark F. Stinski

ABSTRACT Human cytomegalovirus (HCMV) expresses several proteins that manipulate normal cellular functions, including cellular transcription, apoptosis, immune response, and cell cycle control. The IE2 gene, which is expressed from the HCMV major immediate-early (MIE) promoter, encodes the IE86 protein. IE86 is a multifunctional protein that is essential for viral replication. The functions of IE86 include transactivation of cellular and viral early genes, negative autoregulation of the MIE promoter, induction of cell cycle progression from G0/G1 to G1/S, and arresting cell cycle progression at the G1/S transition in p53-positive human foreskin fibroblast (HFF) cells. Mutations were introduced into the IE2 gene in the context of the viral genome using bacterial artificial chromosomes (BACs). From these HCMV BACs, a recombinant virus (RV) with a single amino acid substitution in the IE86 protein was isolated that replicates slower and to lower titers than wild-type HCMV. HFF cells infected with the Q548R RV undergo cellular DNA synthesis and do not arrest at any point in the cell cycle. The Q548R RV is able to negatively autoregulate the MIE promoter, transactivate viral early genes, activate cellular E2F-responsive genes, and produce infectious virus. This is the first report of a viable recombinant HCMV that is unable to inhibit cellular DNA synthesis in infected HFF cells.


PLoS ONE ◽  
2012 ◽  
Vol 7 (10) ◽  
pp. e45686 ◽  
Author(s):  
Emma Poole ◽  
Mark Bain ◽  
Linda Teague ◽  
Yoshinori Takei ◽  
Ron Laskey ◽  
...  

1988 ◽  
Vol 62 (9) ◽  
pp. 3341-3347 ◽  
Author(s):  
J Schickedanz ◽  
L Philipson ◽  
W Ansorge ◽  
R Pepperkok ◽  
R Klein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document